Population Pharmacokinetic Modeling of a Subcutaneous Depot for GnRH Antagonist Degarelix

By Tornøe Christoffer W.   Agersø Henrik   Nielsen Henrik A.   Madsen Henrik   Jonsson E. Niclas  

Pharmaceutical Research, Vol. 21, Iss. 4, 2004-04 ,pp. : 574-584

Springer Publishing Company

Access to resources Recommend Favorite

Semi-Mechanistic Pharmacodynamic Modeling for Degarelix, a Novel Gonadotropin Releasing Hormone (GnRH) Blocker

By Jadhav Pravin   Agersø Henrik   Tornøe Christoffer   Gobburu Jogarao  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 5, 2006-10 ,pp. : 609-634

Springer Publishing Company

Access to resources Recommend Favorite

Non-Linear Mixed-Effects Models with Stochastic Differential Equations: Implementation of an Estimation Algorithm

By Overgaard Rune   Jonsson Niclas   Tornøe Christoffer   Madsen Henrik  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 1, 2005-02 ,pp. : 85-107

Springer Publishing Company

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis

By Franco JG   Baruffi RLR   Mauri AL   Petersen CG   Felipe V   Cornicelli J   Cavagna M   Oliveira JBA  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 618-627

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite